Voluntary exercise increases survival and exercise capacity in a monocrotaline-induced pulmonary hypertension in rats

M. Gouveia (Vicosa, Brazil), M. Gouveia Silva (Vicosa, Brazil), L. Lopes Soares (Vicosa, Brazil), F. Rios Drummond (Vicosa, Brazil), M. Ribeiro Fidelis (Vicosa, Brazil), A. Jayme Lopes Dantas Costa (Vicosa, Brazil), L. Mateus Teixeira Rezende (Vicosa, Brazil), A. Gomes De Moura (Vicosa, Brazil), A. Jose Natali (Vicosa, Brazil)

Source: International Congress 2018 – Cardiopulmonary exercise testing in COPD and cardiovascular diseases
Session: Cardiopulmonary exercise testing in COPD and cardiovascular diseases
Session type: Thematic Poster
Number: 2465
Disease area: Airway diseases, Respiratory critical care

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Gouveia (Vicosa, Brazil), M. Gouveia Silva (Vicosa, Brazil), L. Lopes Soares (Vicosa, Brazil), F. Rios Drummond (Vicosa, Brazil), M. Ribeiro Fidelis (Vicosa, Brazil), A. Jayme Lopes Dantas Costa (Vicosa, Brazil), L. Mateus Teixeira Rezende (Vicosa, Brazil), A. Gomes De Moura (Vicosa, Brazil), A. Jose Natali (Vicosa, Brazil). Voluntary exercise increases survival and exercise capacity in a monocrotaline-induced pulmonary hypertension in rats. 2465

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exercise training in pulmonary hypertension improves muscle efficiency and exercise capacity
Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension
Year: 2008

Experimental hypoxia-induced pulmonary hypertension is prevented by moderate exercise training in mice
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011

Effect of treatment on exercise endurance tolerance and ventilatory efficiency in patients with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011

Hemodynamic correlates of exercise capacity in patients with pulmonary hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 17s
Year: 2005

Deleterious effects of ß-blockers on exercise capacity and hemodynamics in portopulmonary hypertension
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005


Pulmonary hypertension reduces exercise tolerance in COPD
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010

Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016

Aerobic exercise capacity in COPD patients with and without pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009


Pulmonary haemodynamics during exercise in patients with pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension
Year: 2005

Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension
Source: Eur Respir J 2008; 32: 393-398
Year: 2008



Impact of 3-months COVID-19 lockdown on exercise capacity in stable pulmonary arterial hypertension
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021


Effects of high and moderate-intensity exercise training on pulmonary emphysema in Wistar rats
Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans
Year: 2009


Effects of oxygen supplementation during exercise on hemodynamic responses in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease
Year: 2020


Pathophysiology of exercise limitation in patients with pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension
Year: 2005

Impairment of respiratory muscle function in pulmonary hypertension
Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension
Year: 2007




Effects of exercise training in patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2009; 34: 669
Year: 2009



Long-term bosentan therapy improves exercise capacity and hemodynamics in sarcoidosis-associated pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments
Year: 2012


Contrasting cardiopulmonary responses to incremental exercise in patients with schistosomiasis-associated and idiopathic pulmonary arterial hypertension with similar resting hemodynamic impairment
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011

Exercise testing in pulmonary arterial hypertension and in chronic heart failure
Source: Eur Respir J 2004; 23: 747-751
Year: 2004



Exercise training in pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 641s
Year: 2006